Investor Overview Press Releases April 8, 2026 Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference March 27, 2026 Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138 March 20, 2026 Aclaris Therapeutics Announces Poster on Results from Phase 2a Trial of ATI-2138 at the 2026 American Academy of Dermatology (AAD) Annual Meeting View all » Events Apr 14, 202612:00 PM EDT H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference Mar 10, 20261:40 PM EDT Leerink Global Healthcare Conference Feb 26, 20268:40 AM EST Oppenheimer 36th Annual Healthcare Life Sciences Conference View all » Feature Presentation March 2026 Corporate Overview
April 8, 2026 Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference
March 27, 2026 Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138
March 20, 2026 Aclaris Therapeutics Announces Poster on Results from Phase 2a Trial of ATI-2138 at the 2026 American Academy of Dermatology (AAD) Annual Meeting
